InvestorsObserver
×
News Home

Corvus Pharmaceuticals Inc (CRVS) Down 2.73% in Premarket Trading

Friday, June 24, 2022 07:41 AM | InvestorsObserver Analysts

Mentioned in this article

Corvus Pharmaceuticals Inc (CRVS) Down 2.73% in Premarket Trading

Corvus Pharmaceuticals Inc (CRVS) is down -2.73%% today.

Overall Score - 76
CRVS has an Overall Score of 76. Find out what this means to you and get the rest of the rankings on CRVS!
CRVS stock closed at $1.10 and is down -$0.03 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. CRVS has a strong overall score of 76 meaning the stock holds a better value than 76% of stocks at its current price. InvestorsObserver's overall ranking system is a comprehensive evaluation and considers both technical and fundamental factors when evaluating a stock. The overall score is a great starting point for investors that are beginning to evaluate a stock. CRVS gets a average Short-Term Technical score of 60 from InvestorsObserver's proprietary ranking system. This means that the stock's trading pattern over the last month have been neutral. Corvus Pharmaceuticals Inc currently has the 126th highest Short-Term Technical score in the Biotechnology industry. The Short-Term Technical score evaluates a stock's trading pattern over the past month and is most useful to short-term stock and option traders.
Corvus Pharmaceuticals Inc's Overall and Short-Term Technical score paint a strong picture for CRVS's recent trading patterns and forecasted price. Click Here To Get The Full Report on Corvus Pharmaceuticals Inc (CRVS)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App